2017 American Transplant Congress
Efficacy and Safety of ASP0113 versus Placebo in CMV-Seronegative Kidney Transplant Patients Receiving an Organ from a CMV-Seropositive Donor.
Introduction: ASP0113 is a first-in-class DNA-based vaccine in development for the prevention of human cytomegalovirus (CMV) infection in at-risk hematopoietic cell transplant and solid organ…2017 American Transplant Congress
Influenza Viral Dynamics in a Large Cohort of Transplant Patients with Natural Influenza Infection.
Background:Influenza infection significantly impacts transplant patients. Despite this, there are limited data on how virological characteristics, including influenza viral load (VL), impact the outcome of…2016 American Transplant Congress
An Economical and Effective Vaccination Program in Patients Transplanted for Hepatitis B Virus Related Liver Diseases: A Prospective Study.
Aims: To prospectively investigate the efficacy and safety of procedural HBV vaccination in patients transplanted for HBV related liver diseases for prevention of hepatitis B…2016 American Transplant Congress
Vaccination of the Pediatric Patient After Transplantation – Attitudes and Knowledge of the General Pediatrician.
Background: Studies have shown that compliance with post-transplant vaccinations in children is low. Postulated reasons for such low vaccination rates include the lack of familiarity…2016 American Transplant Congress
Post-Transplant Vaccine Initiative Collaboration (VIC) in a Multidisciplinary, Transplant Ambulatory Setting.
1Colonia Natural Pharmacy, Colonia; 2Medicine/Surgery, Drexel University, Philadelphia.
Introduction We describe the implementation of a vaccine initiative in an ambulatory transplant setting.Methods In 2014, Hahnemann University Hospital (HUH) and Colonia Natural Pharmacy transplant…2016 American Transplant Congress
Vaccination Compliance in Listed Kidney Transplant Candidates: A Retrospective Chart Review.
Background: Infections in solid organ transplant recipients, some of which are vaccine preventable, may result in excessive morbidity and mortality. Immunosuppressive agents increase the risk…2016 American Transplant Congress
Assessing Vaccination Status in Transplant Candidates and Recipients: Current Status and Challenges to Successful Implementation.
Northwestern University Feinberg School of Medicine, Chicago, IL.
Background: Vaccines are safety and efficacy of vaccines in transplant candidates and recipients. Several studies have demonstrated significant underutilization of vaccines which increases the risk…2016 American Transplant Congress
Vaccination Status and Titers Before and After Pediatric Renal Transplantation: An Analysis of the CERTAIN Registry.
Purpose:Prevention of systemic viral and bacterial infections by effective vaccination in kidney allograft recipients is of vital importance, but data on the vaccination status in…2016 American Transplant Congress
One Year Post VZV Booster: Still Equal Response in Renal Transplant Recipients Compared to Healthy Persons.
Introduction: Herpes zoster occurs more frequently and with more complications in solid organ transplant recipients than in age matched healthy persons. Vaccination could prevent herpes…2016 American Transplant Congress
High Incidence of Herpes Zoster After Kidney, Liver, Heart and Lung Transplantation.
Erasmus MC, Rotterdam, Netherlands.
Background: Primary varicella zoster virus (VZV) infection causes varicella and lifelong latent infection in neural ganglia from which it may reactivate leading to herpes zoster…
American Transplant Congress abstracts